Current Issue March 2012, Vol. 10, No. 1

Issue Highlights

  • 50 years of the EORTC and the central role of the EORTC Headquarters
    March 2012(Vol. 10 | No. 1 | Pages 3-12)

    Denis Lacombe, John Bean, Jan Bogaerts, Andrew Bottomley, Laurence Collette, Caroline Gilotay, Ann Marinus, Sandrine Marréaud, Pascal Ruyskart, Richard Sylvester, Françoise Meunier

  • Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century
    March 2012(Vol. 10 | No. 1 | Pages 13-19)

    L. Collette, J. Bogaerts, S. Suciu, C. Fortpied, T. Gorlia, C. Coens, M. Mauer, B. Hasan, S. Collette, M. Ouali, S. Litière, J. Rapion, R. Sylvester

  • EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
    March 2012(Vol. 10 | No. 1 | Pages 20-26)

    Wolfgang Wick, Martin van den Bent, Charles Vecht, Alba Brandes, Denis Lacombe, Thierry Gorlia, Anouk Allgeier, Brigitta G. Baumert, Riccardo Soffietti, Marc Sanson, Abul B.M.F. Karim, Réne-Olivier Mirimanoff, Martin Taphoorn, Max Kros, Monika Hegi, Roger Stupp, on behalf of the EORTC Brain Tumor Group

  • Progression-free survival as an end-point in clinical trials of biotherapeutic agents
    December 2007 (Vol. 5 | No. 9 | Pages 23-28)

    Lothar Bergmann, Steven Hirschfeld, Charles Morris, Sergio Palmeri, Andrew Stone, Biotherapy Development Association (BDA)

  • The curability of breast cancer: present and future
    September 2003 (Vol. 1 | No. 1 | Pages 24-34)

    G.N. Hortobagyi

  • Mechanisms and consequences of chemotherapy resistance in breast cancer
    March 2009 (Vol. 7 | No. 1 | Pages 3-7)

    Helen M. Coley

  • Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
    November 2006 (Vol. 4 | No. 11 | Pages 3-13)

    Michel Marty, Gregor Sersa, Jean Rémi Garbay, Julie Gehl, Christopher G. Collins, Marko Snoj, Valérie Billard, Poul F. Geertsen, John O. Larkin, Damijan Miklavcic, Ivan Pavlovic, Snezna M. Paulin-Kosir, Maja Cemazar, Nassim Morsli, Declan M. Soden, Zvonimir Rudolf, Caroline Robert, Gerald C. O’Sullivan, Lluis M. Mir

  • Prognostic factors in advanced renal cell cancer
    October 2008 (Vol. 6 | No. 14 | Pages 35-37)

    Camillo Porta, Ilaria Imarisio, Chiara Paglino, Elisa Ferraris, Mario Mensi, Bruno Rovereto

Most Read lists are compiled every quarter.

On the Cover

Cover Image

New Issue Alert

Visit EJC

Publishing Information

ElsevierEuropean Journal of Cancer is published by Elsevier for The European Organisation for Research and Treatment of Cancer (EORTC), The European Association for Cancer Research (EACR), The European CanCer Organisation (ECCO), and The European Society of Breast Cancer Specialists (EUSOMA).

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About EJC Supplements

Supplements to the European Journal of Cancer (ISSN: 0959-8049) are published under the title of the European Journal of Cancer Supplements (ISSN: 1359-6349).

European Journal of Cancer Supplements is an official journal of the European Organisation for Research and Treatment of Cancer, ECCO - the European CanCer Organisation, the European Association for Cancer Research, the European Society of Breast Cancer Specialists, and the European School of Cancer.

The publication of supplements is subject to rigorous peer-review and to the approval of the Editor-in-Chief. Supplements may include abstracts from international and national meetings, as well as coverage of specialist topics. All supplements are published in print and online. For more information about the European Journal of Cancer Supplements, please contact:

Gemma Schaepman
Elsevier
Telephone: +31 20 485 2930
Email: g.schaepman@elsevier.com

Society Information

EORTC

ECCO

EACR

EUSOMA

More Information